Phase I: Adverse reactions/events related to blood chemistry, blood routine, blood coagulation function and urinalysis indicators 4 days after vaccination with one dose of investigational product.;Phase I: Incidence of solicited adverse events (AEs);Phase I: Incidence of unsolicited adverse events (AEs)

Phase I: Adverse reactions/events related to blood chemistry, blood routine, blood coagulation function and urinalysis indicators 4 days after vaccination with one dose of investigational product.;Phase I: Incidence of solicited adverse events (AEs);Phase I: Incidence of unsolicited adverse events (AEs)